Pharmaceutical Business review -
Popular
- Delpharm plans $140m investment to upgrade Boucherville facility in Canada
- Health Canada approves Arcutis’ roflumilast cream 0.15% for atopic dermatitis
- FDA grants orphan drug status for Korro Bio’s AATD therapy
- FDA clears PDS Biotechnology’s Versamune MUC1 combo for mCRC
- LGM Pharma to expand manufacturing capabilities with $6m investment